Current guidelines do not recommend switching between different levothyroxine products due to concerns of potential changes in TSH levels. However, getting the same levothyroxine product every time may be difficult for patients due to financial or stocking constraints. Join your host, Geoff Wall, and guest, Dr. Jamie Pitlick to discuss a recent study that examined the consequences of switching between levothyroxine products.
Based on a recent study, switching between different levothyroxine products may not significantly or clinically impact TSH levels in patients.
00:00 – Introduction
01:12 – Generic Substitution of Generic Levothyroxine Products
03:17 – Bioequivalence of Levothyroxine Products
15:42 – The GameChanger
24:47 – Closing Remarks
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jamie Pitlick, PharmD, BCPS, PC-ADM
Associate Professor of Pharmacy Practice, Drake University
Diabetes/Endocrinology Care, Iowa Diabetes
References and Resources
Redeem your CPE or CME credit here!
Need a membership?
Continuing Education Information:
1. Describe the outcomes of the study evaluating the impact of switching levothyroxine generic manufacturers
2. Discuss with patients the results of the study and clinical implications
Dr. Wall is a member of the Janssen Speaker's Bureau.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-144-H01-P
Initial release date: 04/11/22
Expiration date: 04/11/2023
Additional CPE & CME details can be found here!